Trade OXFORD INSTRUMENTS PLC ORD 5P - OXIG CFD

Trading Conditions

• Type:
  CFD

  

  Knock-out

  
• Spread: 0.102
• Long position overnight funding adjustment: -0.02126%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: GBP
• Min traded quantity: 1
• Margin: 20.00%
• Stock exchange: Great Britain
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 29.81
• Open: 30.089
• 1-Year Change: 59.87%
• Day's Range: 30.049 - 30.569

Trade OXFORD INSTRUMENTS PLC ORD 5P - OXIG CFD

About Oxford Instruments plc

Oxford Instruments plc is a United Kingdom-based provider of technology products and services to the industrial companies and scientific research communities across the world. The Company's segments include Materials & Characterisation, Research & Discovery and Service & Healthcare. Materials & Characterisation segment comprises a group of businesses focusing on applied research and design and commercial customers, enabling the fabrication and characterization of materials and devices down to the atomic scale. Research & Discovery segment comprises a group of businesses providing solutions that create environments and enable measurements down to the molecular and atomic level, which are used in fundamental research. Service & Healthcare segment provides customer service and support for the Company's products and the service of third-party healthcare imaging systems. Its product categories include Atomic Force Microscopy, Electron Microscopy and Low-Temperature Systems, among others.

Financial summary

BRIEF: For the six months ended 30 September 2021, Oxford Instruments plc revenues increased 21% to £170.1M. Net income increased 4% to £16.5M. Revenues reflect Materials & Characterisation segment increase of 30% to £84.9M, Research & Discovery segment increase of 17% to £56.3M, Service & Healthcare segment increase of 8% to £28.9M. Net income was partially offset by Service & Healthcare segment income decrease of 1% to £8.9M.